Profund Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
8,166
+2,203
+37% +$303K 0.04% 277
2025
Q1
$1.08M Sell
5,963
-358
-6% -$64.5K 0.05% 280
2024
Q4
$990K Sell
6,321
-3,664
-37% -$574K 0.04% 301
2024
Q3
$1.82M Buy
9,985
+1,292
+15% +$235K 0.07% 207
2024
Q2
$1.6M Buy
8,693
+140
+2% +$25.7K 0.06% 215
2024
Q1
$1.52M Sell
8,553
-5,229
-38% -$930K 0.06% 224
2023
Q4
$1.71M Buy
13,782
+1,542
+13% +$191K 0.07% 203
2023
Q3
$1.42M Buy
12,240
+2,375
+24% +$276K 0.08% 202
2023
Q2
$1.16M Sell
9,865
-1,716
-15% -$201K 0.06% 283
2023
Q1
$927K Buy
+11,581
New +$927K 0.06% 320